Differential activation of Brucella-reactive CD4+ T cells by Brucella infection or immunization with antigenic extracts
about
Expression and bactericidal activity of nitric oxide synthase in Brucella suis-infected murine macrophages.The Brucella abortus phosphoglycerate kinase mutant is highly attenuated and induces protection superior to that of vaccine strain 19 in immunocompromised and immunocompetent miceProtection of mice against brucellosis by vaccination with Brucella melitensis WR201(16MDeltapurEK).Non-major histocompatibility complex control of antibody isotype and Th1 versus Th2 cytokines during experimental infection of mice with Mycobacterium avium.Induction of specific cytotoxic lymphocytes in mice vaccinated with Brucella abortus RB51.Recombinant Ochrobactrum anthropi expressing Brucella abortus Cu,Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 typeIdentification of a quorum-sensing signal molecule in the facultative intracellular pathogen Brucella melitensis.Label-free microcavity biosensors: steps towards personalized medicine.Endogenous interleukin-12 is involved in resistance to Brucella abortus infection.Enhanced immune response of red deer (Cervus elaphus) to live rb51 vaccine strain using composite microspheresWhat have we learned from brucellosis in the mouse model?Immunogenic response of Brucella canis virB10 and virB11 mutants in a murine model.Immunization with a single dose of a microencapsulated Brucella melitensis mutant enhances protection against wild-type challenge.Brucellosis: an overview.The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB/c mice when delivered in a sustained-release vehicleCD8 knockout mice are protected from challenge by vaccination with WR201, a live attenuated mutant of Brucella melitensis.Host susceptibility to Brucella abortus infection is more pronounced in IFN-γ knockout than IL-12/β2-microglobulin double-deficient mice.Liposomal delivery of p-ialB and p-omp25 DNA vaccines improves immunogenicity but fails to provide full protection against B. melitensis challenge.Subcellular fractions of Brucella ovis distinctively induce the production of interleukin-2, interleukin-4, and interferon-gamma in mice.Alternative strategies for vaccination to brucellosis.An Autoimmune Disease-Associated Risk Variant in the TNFAIP3 Gene Plays a Protective Role in Brucellosis That Is Mediated by the NF-κB Signaling Pathway.Protective humoral and CD4+ T cellular immune responses of Staphylococcus aureus vaccine MntC in a murine peritonitis model.
P2860
Q33752010-9F3238DE-A01F-4B9C-B716-122670FC726EQ33826026-C08CD396-294A-46D8-A330-DEF619527851Q34002465-35568F3D-B1CC-42FC-A0FB-5E4F7BA4993CQ34006443-7C170B11-3352-4F51-A1CB-B1979BDBCA89Q34008913-42803BF0-D359-4559-8436-C757B130B98EQ34121084-B23FC0B0-2A27-4026-9223-8026922DF383Q34123343-42DE9CA4-3E79-44F5-B0FD-730865761E49Q34601506-BEDBEE3C-C787-4DE1-AC60-982DB6CAE194Q35401154-ECAD7E1C-C49B-462E-83B8-79A054BBA336Q35954584-5FBCE9FC-D283-43AB-8120-59C5E2CF6790Q36136716-FF7FE442-197A-4869-A164-1C454EEF0315Q36158852-D5BA446B-853F-47FD-93AB-52318749593EQ36710777-19F7AD32-FF55-4A56-BBDE-61A030CCE934Q37064103-897EDAEF-4A46-4226-9EBE-02B665CB03D4Q37075414-6CB520A7-DDFB-42A2-AA5F-4B57EFAC6968Q37316341-DD63BF1A-7E5F-4E7E-891A-6E1E1F9F578AQ39802365-D5023FFA-A29A-4EF9-A05F-28980D3FCDC4Q41761576-7C318563-0AE9-406D-B746-4CDF4737600BQ42204807-23D68ABF-15B0-4424-8731-DFB24E03D5AFQ49486807-EB5F4930-3B99-4E13-B23C-DB6EAA784517Q49990245-C6918615-9159-4F48-A198-30706B9E7E6FQ53706343-B6AE01BB-7D7C-461A-B8EE-91B4ECB3F906
P2860
Differential activation of Brucella-reactive CD4+ T cells by Brucella infection or immunization with antigenic extracts
description
1995 nî lūn-bûn
@nan
1995 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մարտին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
name
Differential activation of Bru ...... zation with antigenic extracts
@ast
Differential activation of Bru ...... zation with antigenic extracts
@en
type
label
Differential activation of Bru ...... zation with antigenic extracts
@ast
Differential activation of Bru ...... zation with antigenic extracts
@en
prefLabel
Differential activation of Bru ...... zation with antigenic extracts
@ast
Differential activation of Bru ...... zation with antigenic extracts
@en
P2860
P1476
Differential activation of Bru ...... zation with antigenic extracts
@en
P2860
P304
P407
P50
P577
1995-03-01T00:00:00Z